The balance between antiapoptotic and proapoptotic proteins of the Bcl-2 family is critical in determining the fate of T cells in response to death stimuli. Proapoptotic genes, such as bax, are generally regulated by the p53 family of transcription factors, whereas NF-jB subunits can activate the transcription of antiapoptotic Bcl-2 members. Here, we show that CD28 activation protects memory T cells from irradiation-induced apoptosis by both upregulating bcl-xL and inhibiting bax gene expression. We found that p73, but not p53, binds to and trans-activates the bax gene promoter in irradiated T cells. The activation of RelA/NF-jB subunit in CD28 costimulated T cells and its binding onto the bax gene promoter results in suppression of bax transcription and decrease in both p73 and RNA polymerase II recruitment in vivo. RelA recruitment on the bax gene promoter is also accompanied by the lost of p300 binding and the parallel appearance of histone deacetylase-1-containing complexes. These findings identify RelA/NF-jB as a critical regulator of T-cell survival by affecting the balance of Bcl-2 family members.
Apoptosis of T lymphocytes is a physiological mechanism by which an efficient immune system prevents autoimmunity and ensures T-cell homeostasis. 1 The regulation of Bcl-2 family proteins represents a critical checkpoint in the apoptotic pathway and is important to determine the cell fate in the lymphoid system. The Bcl-2 family comprises multidomain proteins with antiapoptotic (Bcl-2, Bcl-xL, Bcl-W, 1, A1Bfl-1) and proapoptotic functions (Bax, Bak, Bid, Bim, Hrk), and a subset of proapoptotic members known as BH3-only proteins with regulatory functions. The BH3-only proteins (i.e., Bid, Bad, Bim, Noxa, Puma) communicate both extrinsic (death receptor, growth factor, T-cell receptor (TCR)) and intrinsic death stimuli (DNA damage) to Bax and Bak favoring their oligomerization, the release of cytochrome c from the mitochondrial membrane and subsequently inducing cell death. The balance between proapoptotic (Bax, Bak) and antiapoptotic members (Bcl-2, Bcl-xL) determines how the cell will respond to an apoptotic signal. 2, 3 Indeed, antiapoptotic members of the Bcl-2 family may sequester the proapoptotic proteins, thus preventing mitochondrial damage and apoptosis. 4 In summary, the downregulation of antiapoptotic and the induction of proapoptotic members of the Bcl-2 family, such as Bax, are required to activate the cell death programs.
The transcription factor NF-kB can be considered a major regulator of lymphocyte survival. In mammals, this family consists of five members that form homo-and heterodimeric complexes, including NF-kB1 (p50 and its precursor p105), NF-kB2 (p52 and its precursor p100), RelA (p65), RelB and c-Rel. RelA, RelB and c-Rel contain trans-activating domains (TADs) and are able to activate transcription. p50 and p52 lack a TAD and therefore may form transcriptionally active heterodimers in association with RelA, RelB and c-Rel. 5 NF-kB activity is regulated by inhibitory proteins belonging to the IkB family (which include IkBa, IkBb and IkBe), with the function to retain NF-kB dimers in the cytoplasm. A protein kinase complex, known as IKK signalsome, phosphorylates IkBa, IkBb and IkBe, inducing their proteolytic degradation and the subsequent translocation of NF-kB into the nucleus. 6 NF-kB activation can suppress cell death pathways through the transcriptional activation of the Bcl-2 homologues A1/Bfl-1 and Bcl-xL. Recently, NF-kB has been also involved in the downregulation of Bax expression, in some human cancers (colon, breast and ovarian cancer cell lines) 7 and in EpsteinBarr virus-infected B cells. 8 Transcription of the bax gene is controlled by several transcription factors, including the tumor suppressor proteins belonging to p53 family. 9 Bax promoter contains a DNA consensus sequence for binding of the tumor suppressor protein p53. Exogenously expressed p53 increases bax expression in several cell types, and this increase correlates with the induction of apoptosis. 10 In some cell lines, p53 binds the bax gene promoter weakly when compared with other target promoters (i.e., puma), suggesting that bax may not represent the major target gene for p53. 11 Recently, another member of the p53 family, p73, with trans-activating potential on the bax gene promoter has been identified. p73 is expressed in multiple isoforms (p73 a-z), derived from alternative splicing at the 3 0 . 12,13 Interestingly, whereas p53 serves as a checkpoint protein for DNA damage, p73 integrates stimuli for both DNA damage and receptormediated apoptosis in T cells.
14 A connection between p73 and the NF-kB pathway has been recently proposed in T lymphocytes, where costimulation-induced NF-kB activity has been related to the inhibition of p73 expression. 15 Thus, an interplay between NF-kB and p73 exists that may play an important role in regulating the fate of T lymphocytes.
Here, we report that CD28 engagement by B7 protects memory T cells from irradiation-induced apoptosis, by modulating the expression of both anti-and proapoptotic proteins of the Bcl-2 family. We found that in irradiated T cells p73, but not p53, binds to and trans-activates the bax gene promoter and that CD28 costimulation inhibits p73-induced bax transcription. The RelA/NF-kB subunit in CD28-costimulated T cells suppresses bax gene transcription by a direct binding to the bax gene promoter and interferes with the recruitment of both p73 and RNA polymerase II (pol II). Data obtained by using specific inhibitors evidenced the involvement of PI3K/Akt pathway in CD28-mediated inhibition of both Bax expression and apoptosis. These findings reveal a new mechanism by which NF-kB can promote T-cell survival.
Results
CD28 costimulation protects T cells from radiationinduced apoptosis by regulating both bcl-xL and bax transcriptional activation. We have recently demonstrated that CD28 ligation by B7 in the absence of TCR stimulation protects memory T cells from ionizing radiation (IR)-induced apoptosis and induces the recruitment of RelA on the bcl-xL gene promoter, thus upregulating Bcl-xL expression 16 (Supplementary Figure 1) . Starting from these data, we analyzed the effects of CD28-mediated survival signals on the expression of proapoptotic genes. In particular, we looked at the transcription of bim, puma and bax genes, being the major mediators of mitochondria-dependent apoptosis. Bax gene transcription was induced as early as 2 h post irradiation and started to decrease after 8 h (Figure 1a) . By contrast, bim and puma expressions, which were efficiently upregulated in PMA-treated human memory T cells, were not induced following IR treatment (Figure 1a , middle panels). CD28 stimulation strongly inhibited bax (Figure 1a , lanes 4 and 5 versus 2 and 3). Consistently with our recent data, 16 bcl-xL gene expression was induced 8 h after CD28 engagement (Figure 1a , upper panel, lane 5). Bax gene transcription was also accompanied by a strong increase of Bax protein levels, which were significantly reduced following CD28 stimulation (Figure 1b , upper panel). We also analyzed the expression of both p53 and p73 proteins, being involved in the regulation of proapoptotic gene expression during IR-induced apoptosis. 17, 18 We found that primary T cells expressed basal protein levels of p73, which did not change following irradiation (Figure 1b , middle panel). On the basis of its molecular weight (B80 kDa) and co-migration with exogenously expressed HA-p73a (Supplementary Figure 3, lower panel) , the p73 isoform found in T cells is likely p73a. Although no significant changes in p73 protein levels were observed in IR-treated T cells, data obtained from radioactive RT-PCR evidenced an early (2 h after IR) and transient induction of p73a transcription that was completely inhibited following CD28 stimulation (Figure 1c, upper panel) . By contrast, p53 levels were strongly induced after IR and were not affected by CD28 (Figure 1b, middle panel) . No change in RelA content was observed in IR-treated cells (Figure 1b, lower panel) .
The analysis of bax gene promoter occupancy by chromatin immunoprecipitation (ChIP) experiments revealed that p73 was recruited on the promoter in the early phase of IR-induced transcriptional activation (Figure 1d, upper panel, lanes 1-3) . By contrast, endogenous p53 did not bind the bax gene promoter in irradiated T cells (Figure 1d , middle panel), although it was recruited on to the DNp73 promoter and efficiently trans-activated it (Figure 3c and d) . The induction of DNp73 expression by p53 has been described to create dominant-negative feedback loop that fine tunes the function of p53. 19 The relevance of p73 in IR-induced apoptosis was evidenced by the silencing with oligonucleotide small interfering RNA (siRNA) duplexes, which specifically downregulate the expression of several p73 isoforms ( Figure 2b ). As shown in Figure 2a , the inhibition of p73 expression was associated with a significant reduction (around 40%) of IR-induced apoptosis (Figure 2a Figure 2d , upper panels). Consistently with our previous data, 16 RelA was recruited on and trans-activated the bcl-xL gene promoter (Figure 2d , middle panel, lanes 4 and 5). Altogether these data indicate that the in vivo recruitment of RelA/NF-kB on the bax gene promoter in CD28-costimulated T lymphocytes is paralleled by a decrease in IR-induced p73 recruitment and transcriptional activity.
The bax gene promoter is trans-activated by p73, but not p53, in Jurkat cells. To further define the role of p73 in the trans-activation of the bax gene promoter, we used a Jurkat T cell line that expresses endogenous p73, but not detectable p53, undergoes apoptosis and upregulates Bax after IR (data not shown). Jurkat cells were transfected with a bax-luciferase reporter construct, containing the luciferase gene under the control of the bax promoter (À715 to À317 bp), in the presence of either HA-tagged p73 (aÀd) or Flag-p53 expression vectors. All the p73 isoforms were able to trans-activate the bax promoter, although to different degrees ( Figure 3a) , with p73a and p73g being the most potent trans-activators. By contrast, p53 did not significantly upregulated bax expression under the same experimental conditions, although it was able to bind and trans-activate the DNp73 promoter both in vitro ( Figure 3c ) and in IR T cells (Figure 3d ). Similar results were obtained in another T cell line (Hut-78), thus indicating that in T cells p53 does not regulate bax transcription as observed in other cancer cell lines 10 (data not shown). The bax gene promoter contains four potential p53-binding sites. These binding sites reside within a 39-bp region (À486 to -448 bp) that has been identified as sufficient for p53-mediated trans-activation 10 and to bind exogenous HA-p73a in EMSA assays (data not shown). Consistently with the high homology shared by p53 and p73 in their DNA-binding domain as well as in their ability to activate largely overlapping sets of genes, 9 p73-induced bax transcription depended on the presence of its TAD, as demonstrated by the inability of a p73a mutant (D85p73a), lacking the TAD, to significantly upregulate bax-luciferase activity (Figure 4a ). Furthermore, p73a was not able to trans-activate the mutp53 bax-luciferase vector (Figure 4c ), containing three nucleotide substitutions within one of the consensus p53-binding sites (À474 to À465 bp). RelA/NF-jB subunit antagonizes p73-induced bax transcription and inhibits both p73 and RNA pol II recruitment onto the bax gene promoter. We next tested different NF-kB subunits for their ability to inhibit p73-induced bax transcription. Jurkat cells were transfected with baxluciferase construct together with p73a in the presence or absence of individual HA-tagged RelA, RelB plasmids or expression vectors encoding for p50 or p52. RelA/p65 strongly interfered with p73-mediated bax transcription when overexpressed in Jurkat cells (Figure 5a ), whereas the other NF-kB subunits did not exert any significant effects (Figure 5a and b) . The increase in the bax-luciferase activity observed in Jurkat cells overexpressing p50 and p52 was related to a higher p73 expression (Figure 5b , right panels).
The bax gene promoter contains three putative binding sites for NF-kB in the region comprised between À702 and À493 bp. 10 To verify if NF-kB DNA-binding activity was associated to the inhibition of p73-induced transcriptional activation, a mutated bax-luciferase construct (Del-kB), deleted of the putative NF-kB binding region, was generated. Interestingly, the deletion of the NF-kB binding sites significantly increases the ability of p73 to trans-activate the bax gene promoter, whereas RelA inhibitory activity was significantly reduced (Figure 6a ). The apparent increase of both HA-p73 and HA-RelA protein expression observed in Del-kB-transfected cells (Figure 6b ) was not due to higher transfection efficiency, as verified by coexpressing an enhanced green fluorescent protein (eGFP) construct (data not shown). These data together with our observations that RelA neither interacted with p73 nor affected the DNA-binding affinity of p73 for the p53-binding site of the bax promoter in Altogether these results indicate that exogenously expressed RelA/NF-kB subunit antagonizes p73-induced bax transcription by inhibiting p73 recruitment onto the bax gene promoter but do not clarify the mechanisms of RelAmediated repression of bax expression in response to CD28 costimulation. One mechanism may involve the sequestration of key p73 coactivators such as the p300/cAMP-responsive element-binding protein-binding protein (CBP) and/or the recruitment of corepressors histone deacetylase (HDAC) on the bax promoter, as previously demonstrated in other systems. 20, 21 As shown in Figure 6d , CD28 triggering interfered with the recruitment of p73/p300 complexes to the bax gene promoter and promoted the binding of HDAC-1-containing complexes. Moreover, pretreatment of T cells with the HDAC-1 inhibitor trichostatin A (TSA), strongly inhibited the survival signals mediated by CD28 and restored IR-induced Bax expression (Supplementary Figure 2) .
The Akt pathway interferes with p73-mediated transcription of bax gene by inducing RelA recruitment to the bax promoter. The protein kinase B, Akt, has been recently discovered as a critical mediator of survival in T cells, acting specifically downstream of CD28 through the activation of NF-kB. 22, 23 The involvement of Akt and NF-kB in CD28 survival signals was supported by the observation that the inhibitor of PI3K/Akt pathway, LY294002, as well as MG101, a proteasome inhibitor that blocks RelA nuclear translocation and transcriptional activity, without affecting RelA expression (Supplementary Figure 2b, middle panel) , restored both IR-induced apoptosis and Bax protein levels in CD28-costimulated T cells, without affecting p53 levels. Finally, Akt overexpression in Jurkat cells completely 
Discussion
It is well established that members of the Bcl-2 protein family are cardinal regulators of T-cell viability and the ratio of antiapoptotic (Bcl-2, Bcl-xL) to proapoptotic (Bax, Bak) members may be considered a rheostat that determines susceptibility to cell death. Bcl-2 protein activities are regulated by both transcriptional and post-translational mechanisms. However, the mechanisms and the transcription factors that regulate Bcl-2 family members at the promoter level are not completely known, as well as the effects of CD28 costimulation on the expression of other Bcl-2 family members. In this article, we present evidence that CD28 engagement by B7 delivers survival signal in memory T cells by both upregulating bcl-xL and inhibiting p73-mediated bax gene transcription in a RelA/NF-kB-dependent manner.
In T cells, Bax is one of the major proapoptotic agents. Bax deficiency alters both thymic selection and lymphoid homeostasis. 24 The presence of four motifs with homology to consensus p53-binding site in the bax gene promoter and the ability of p53 to trans-activate bax gene when overexpressed in some cancer cell lines, identified bax as a p53 target gene. 10 The use of quantitative ChIP assays has recently revealed that the bax gene promoter binds p53 very weakly, when compared to other p53 target genes, such as noxa and puma, 11 which have been described as critical mediators of the apoptotic responses induced by p53. 25 Consistently, we found that p53 was not recruited to the bax promoter in irradiated T cells (Figure 1d) , although it was able to transactivates bax gene when overexpressed in Cos7 cells or in A2780 ovarian cancer cells (data not shown). Thus, our data indicate that in human T cells p73 is the major regulator of bax gene transcription and is involved in IR-induced apoptosis, as demonstrated by the use of specific siRNA to inhibit p73 expression (Figure 2a) . These data seem apparently in contrast with those obtained from both p53-and p63/p73-deficient mice. 26, 27 However, in both systems apoptosis was analyzed only in IR-treated thymocyte 26, 27 or in mature T cells following TCR restimulation. 26, 27 No data on the susceptibility to IR-induced apoptosis of mature T cells have been shown.
We also show that p73 functions are counteracted by RelA/NF-kB, thus reinforcing the current notions of a cross talk between these two transcription factors in regulating T-cell survival. RelA/NF-kB acts as a key prosurvival factor by regulating the expression of antiapoptotic genes of the Bcl-2 family, in particular A1/Bfl-1 and bcl-xL. However, Bcl-xL upregulation promotes T-cell survival 28 but does not protect T cells from activation-induced cell death (AICD). 29, 30 TCR-AICD has been recently described to depend on both E2F-1 and p73 14 and NF-kB may counteract TCR-driven apoptosis by inhibiting p73 expression. 15 Our data on the ability of RelA to bind the bax gene promoter and to interfere with p73-induced bax transcription evidence a novel mechanism by which NF-kB may regulate T-cell survival. Indeed, RelAmediated inhibition of p73-induced bax gene expression is accompanied by the recruitment of RelA to the bax gene promoter and the parallel inhibition of p73 binding (Figure 2) . Moreover, the deletion of three potential NF-kB binding sites from the bax gene promoter, 7 restores significantly, but not completely, p73-mediated transcriptional activation (Figure 6a ). The putative binding sites for NF-kB and p53/p73 within the bax promoter are very close. 7 Thus, it is conceivable that in on hand the binding of RelA to the bax gene promoter might directly block p73 and RNA pol II recruitment through a mechanism of steric hindrance, as observed for RelAmediated repression of glucocorticoid-receptor-dependent transcription. 31 In another hand, RelA may repress p73-mediated transcription by both sequestering the coactivator p300/CBP and favoring the recruitment of corepressor HDAC complexes (Figure 6d ), as observed in other systems. 20, 21 CD28 is an important regulator of T-cell survival by inducing the expression of antiapoptotic proteins, in particular of Bcl-xL. 28 Data from Bcl-xL-deficient mice indicate that Bcl-xL is essential for the survival of double-positive thymocyte but not mature T lymphocytes. 32 We have recently demonstrated that CD28 stimulation, in the absence of TCR, 16 Here, we demonstrate that CD28-delivered signals also inhibit p73-induced bax expression in irradiated T cells, by interfering with p73 and RNA pol II recruitment on the promoter (Figure 2 ). These data evidence that CD28 is able to deliver a unique signal leading to the induction of survival factors and repression of proapoptotic genes.
A possible candidate in mediating CD28-protective signals is Akt. 22, 23 Akt has been also described to inhibit Bax translocation to mitochondria following serum deprivation. 33 Our data on the restoration of both IR-induced apoptosis and Bax levels in CD28-costimulated T cells treated with the PI3K inhibitor LY294002 reveal a further role of Akt in regulating Bax expression. Basu et al. 34 have recently reported that Akt phosphorylates the Yes-associated protein (YAP), thus impairing its nuclear translocation and inhibiting its function as strong transcriptional coactivator of p73. 35 Thus, CD28-mediated activation of Akt may lead to both the inactivation of YAP and the recruitment of RelA-containing repressor complexes 31 on the bax gene promoter (Figure 7c ), thereby completely blocking p73-mediated transcriptional activity.
Materials and Methods Cell lines, antibodies and reagents. Human primary CD4
þ T cells were enriched from peripheral blood mononuclear cells (PBMCs) by MACS microbead sorting (Miltenyi Biotec, Milano, Italy) and cultured in RPMI 1640 supplemented with 5% human serum (Euroclone, UK), L-glutamine, penicillin and streptomycin (Gibco-BRL, Grand Island, NY, USA). The purity of the sorted population was 95-99%. The CD4 þ Jurkat T cell line (clone J106.60) was maintained in RPMI 1640 supplemented with 10% FCS, L-glutamine, penicillin and streptomycin (Gibco-BRL). Murine L cells and L cells expressing human B7.1 (Dap/B7) were previously described. 16 Anti-p65/RelA (C-20), anti-HA (Y11), anti-p73 (H-79), anti-p53 (DO-1), anti-Bax, anti-Akt and anti-RNA pol II Abs were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Anti-p50 (06-886) and anti-p52 (05-361) Abs were purchased from Upstate Biotechnology (Lake Placid, NY, USA). The PI3K inhibitor LY294002 was from Calbiochem (La Jolla, CA, USA), TSA and the proteasome inhibitor MG101 were purchased from Sigma.
Plasmids, cell transfection and luciferase assays. pcDNA3-expressing HA-tagged human p73 isoforms (a, b, g , d), D84p73a-d isoforms and FLAG-p53 have been previously described. 12 HA-tagged p65/RelA and RelB as well as p50 and p52 expression vectors were kindly provided by G Natoli (Department of Experimental Oncology, European Institute of Oncology, Milan, Italy). HA-tagged Akt construct was kindly provided by T Mustelin (The Burnham Institute for Medical Research, La Jolla, CA, USA). Bax-luciferase reporter construct was obtained by subcloning the PCR-generated fragment (À715 to À317 bp) from the bax gene promoter into BglII-HindIII sites of the pGL3-luciferase Enhancer vector (Promega). Mutp53-and Del-kB-luciferase mutants were derived from baxluciferase construct by substituting three nucleotides within the consensus p53-binding sites (À474 to À465 bp), 10 and deleting the three NF-kB binding sites (À708 to À502 bp), 7 respectively, by PCR. The primers used were as follows: mutp53 5 0 -AAGTTAGAGATAATGCTGGGCGTAGG-3 0 and 5 0 -CCTACGCCCAG CATTATCTCTAACTT-3 0 ; Del-kB 5 0 -ATTGGTACCATCTCTTGGGCTTCACAAG TTA-3 0 and 5 0 -TACCGGAATGCCAAGCTTACT-3 0 . The entire sequences of the mutants were verified by DNA sequencing.
Jurkat cells were transiently transfected with the indicated expression vectors as previously described. 36 Luciferase activity was measured according to the manufacturer's instruction (Promega). Transfection efficiency was controlled by coexpressing pEGFP (Clontech), encoding an eGFP. Luciferase activity determined in triplicates was expressed as fold induction over the basal activity of cells transfected with empty vectors and/or as arbitrary luciferase units after normalization to GFP values. 0 and 5% 0 -AGGCACCTAATTGGGCTCCATCTC-3 0 for GAPDH, specific primers have been previously described. 16 PCR products were size fractionated by agarose electrophoresis and normalized according to the amount of GAPDH detected in each sample. p73 transcript analysis. To detect p73 splicing variant expression, radioactive RT-PCR was performed, as previously described, 12 using the following primers: 5 0 -TTCTGCAGGTGACTCAGGCTG-3 0 for RT; and 5 0 -ACTT TGAGATCCTGATGAAG-3 0 (sense primer) and 5 0 -CAGATGGTCATGCGGTACTG-3 0 (antisense primer) for PCR amplification. cDNA synthesis was performed starting with equal concentration of RNA (1 mg). Radioactive PCR was performed in 50 ml of reaction buffer containing 5 ml of the RT product, 50 mM KCl, 10 mM Tris-HCl (pH 9.0), 0.1% Triton X-100, 1.5 mM MgCl 2 , dNTPs 0.2 mM each, cold primers 0.4 mM each, plus 40 nM each of [g-32 P]dATP-labeled primers and 2.5 U of Taq DNA polymerase. Amplifications consist of one cycle at 951C for 5 min followed by 35 cycles at 951C for 60 s, 591C for 55 s and 721C for 45 s. PCR products were separated on a non-denaturating 6% polyacrylamide gel, dried and analyzed by autoradiography.
Immunoblotting. Protein extracts were obtained by lysing cells for 30 min at 41C in lysis buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Nonidet P-40 (NP-40), 0.5% NaDoc and 1% SDS) in the presence of protease and phosphatase inhibitors. Proteins were resolved by SDS-PAGE and blotted onto nitrocellulose membranes. Blots were incubated with the indicated primary antibodies, extensively washed and after incubation with horseradish peroxidase (HRP)-labeled goat anti-rabbit or goat anti-mouse Abs (Amersham Pharmacia), developed with the enhanced chemiluminescence's detection system (Amersham Pharmacia).
ChIP assays. ChIP assays were performed as previously described. 16 Briefly, after fixing in 1% formaldehyde, cells were lysed for 5 min in 50 mM Tris, pH 8.0, 2 mM EDTA, 0.1% NP-40 and 10% glycerol supplemented with proteases inhibitors. Nuclei were resuspended in 50 mM Tris, pH 8.0, 1% SDS and 5 mM EDTA. Chromatin was sheared by sonication, centrifuged and diluted 10 times in 50 mM Tris, pH 8.0, 0.5% NP-40, 0.2 M NaCl, 0.5 mM EDTA. After preclearing with a 50% suspension of salmon sperm-saturated protein A, lysates were incubated at 41C overnight with the indicated antibodies. Immune complexes were collected with sperm-saturated protein A, washed three times with high-salt buffer (20 mM Tris, pH 8.0, 0.1% SDS, 1% NP-40, 2 mM EDTA, 500 mM NaCl) and five times with 1 Â Tris/EDTA (TE). Immune complexes were extracted in 1 Â TE containing 1% SDS, and protein-DNA cross-links were reverted by heating at 651C overnight. DNA was extracted by phenol-chloroform and about 1/20 of the immunoprecipitated DNA was used in each PCR. The primers used were as follows: Bax promoter Apoptosis analysis. Human CD4 þ T cells were exposed to 5 Gy of IR by using an X-ray apparatus (AL filter 3 mm) and then cultured in the presence (B7) or absence (ctr) of adherent Dap/B7 cells for 24 h. Where indicated cells were pretreated for 2 h with either LY294002 (50 mM) or TSA (100 nM) or MG101 (10 mM) before IR. At the end of incubation, cells were carefully resuspended in PBS containing 0.1% Triton X-100 (Sigma) and 100 U/ml RNase A (Sigma), were stained with 50 mg/ml propidium iodide (PI; Sigma) and incubated at 371C for 15 min. Apoptosis was analyzed by a BD Biosciences FACScalibur (BD Biosciences, Mountain View, CA, USA), by a biparametric analysis of FL2-H versus SSC-H graphs. Cells showing a less than 2C DNA content (hypodiploid cells) and high SSC-H (granular, highly condensed cells) were regarded as apoptotic. The mean frequencies of apoptotic cells were calculated at least from three independent experiments and statistically analyzed using Student's t-test. The percentage of specific apoptosis was calculated as follows: % specific apoptosis ¼ 100 Â (% PI þ cellsÀ% spontaneous PI þ untreated cells)/(100À% spontaneous PI þ untreated cells).
siRNA transfection. p73 siRNA and Bax sMART pool siRNA oligonucleotides were purchased from Dharmacon (Chicago, IL, USA) and designed on the sequence of human p73 cDNA encoding the DNA-binding domain (siRNA p73) or GFP (siRNA ctr). The sense strand sequences of the siRNAs were as follows: p73 5 0 -CCAUCCUGUACAACUUCAUGUG-3 0 and GFP 5 0 -GTTCAGCGTGTCCGG CGAG-3 0 . The two siRNAs specific for p53 (A and B) were kindly provided by G Blandino (Department of Experimental Oncology, Regina Elena Cancer Institute, Rome, Italy) and sequences are available upon request.
Primary T-cell blasts were isolated by MACS microbead sorting from PBMCs activated for 4 days with 1 mg/ml phytohemagglutinin and 5 IU/ml recombinant IL-2 (Roche). Cationic lipid complexes, prepared by incubating 5 mg of indicated siRNA with 10 ml Lipofectamine (Invitrogen) in 600 ml Optimem (Invitrogen) for 1 h, were added to 10 7 T-cell blasts in a final volume of 5 ml. After overnight incubation, cells were washed and cultured in RPMI containing 1% FCS for further 24 h. At the end of incubation, p73 expression was analyzed by western blotting, and T cells were exposed to 5 Gy IR and after 24 h apoptosis was evaluated by PI staining.
